SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
FDA Grants Fast Track Designation to Tioga Pharmaceuticals' Asimadoline for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome